The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis
Abstract
Summary: Background: Although incrimination of the intestinal microbiota in the pathogenesis of IBD is widely accepted, few data are available about the role of specific bacteria. Potentially, F aecalibacterium prausnitzii, bacteria with anti‐inflammatory properties, might be deficient in ulcerative colitis (UC). Aim: To quantify F. prausnitzii in the faecal microbiota of UC patients in remission and determine its relationship with relapse. Methods: A cross‐sectional study included 116 UC patients in remission, 29 first‐degree relatives and 31 healthy controls. A subset of eighteen patients, recruited during the first month of remission, underwent a 1‐year follow‐up. Total bacteria and F. prausnitzii were measured by quantitative Real Time PCR (qPCR, copies/g). Calprotectin was determined as inflammatory index (μg/g). Results: We found that F. prausnitzii was reduced in patients (median, IQR: 1.4 × 10 8, 5.1 × 10 7–4.5 × 10 8) and relatives (1.7 × 10 8, 9.3 × 10 7–5.1 × 10 8) vs. controls (6.5 × 10 8, 3.7 × 10 8–1.6 × 10 9, P < 0.0001). Moreover, low counts of F. prausnitzii were associated with less than 12 months of remission (8.0 × 10 7, 2.0 × 10 7–3.5 × 10 8 vs. 2.1 × 10 8, 1.0 × 10 8–7.9 × 10 8, P < 0.001) and more than 1 relapse/year (8.0 × 10 7, 3.2 × 10 7–3.8 × 10 8 vs. 1.9 × 10 8, 6.8 × 10 7–6.0 × 10 8, P < 0.01). When patients were followed up, F. prausnitzii increased steadily until reaching similar levels to those of controls if remission persisted (2.9 × 10 8, 9.3 × 10 6–1.2 × 10 9; calprotectin: 76, 19–212), whereas it remained low if patients relapsed (2.2 × 10 8, 1.4 × 10 6–3.3 × 10 8; calprotectin: 1760, 844–3662 P < 0.05 vs. controls). Conclusions: Defective gut colonisation by F. prausnitzii occurred in UC patients during remission and in their unaffected relatives. The recovery of the F. prausnitzii population after relapse is associated with maintenance of clinical remission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dysbiosis of the faecal microbiota in patients with Crohn’s disease and their unaffected relatives
Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., Vandamme, P., & Vermeire, S. (2011) · Gut · doi:10.1136/gut.2010.223263 · Cited by 1,063
Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission
Martinez, C., Antolin, M., Santos, J., Torrejon, A., Casellas, F., Borruel, N., Guarner, F., & Malagelada, J.-R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01592.x · Cited by 208
Self-citation
Cited by
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Le Berre, C., Honap, S., & Peyrin-Biroulet, L. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00966-2 · Cited by 1,643
Gut microbiota in the pathogenesis of inflammatory bowel disease
Nishida, A., Inoue, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0813-5 · Cited by 1,377
Manichanh, C., Borruel, N., Casellas, F., & Guarner, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.152 · Cited by 1,160
Self-citationMechanisms of Disease: Inflammatory Bowel Diseases
Ramos, G. P., & Papadakis, K. A. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.09.013 · Cited by 1,021
Metadata
- Authors
- Varela, E., Manichanh, C., Gallart, M., Torrejón, A., Borruel, N., Casellas, F., Guarner, F., & Antolin, M.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2013-06-03
- Volume
- 38
- Issue
- 2
- Pages
- 151-161
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W1973835204
- Cited by
- 249
- References
- 2
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.